These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 39117891)

  • 1. The symptoms evolution of long COVID‑19 (SE-LC19): a new patient-reported content valid instrument.
    Rofail D; Somersan-Karakaya S; Mylonakis E; Choi JY; Przydzial K; Marquis S; Zhao Y; Hussein M; Norton TD; Podolanczuk AJ; Geba GP
    J Patient Rep Outcomes; 2024 Aug; 8(1):87. PubMed ID: 39117891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and content validation of the Symptoms Evolution of COVID-19: a patient-reported electronic daily diary in clinical and real-world studies.
    Rofail D; McGale N; Im J; Rams A; Przydzial K; Mastey V; Sivapalasingam S; Podolanczuk AJ
    J Patient Rep Outcomes; 2022 May; 6(1):41. PubMed ID: 35507193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of Patient Reported Outcome Measures (PROMs) for characterizing Long COVID (LC)-merits, gaps, and recommendations.
    Ejalonibu H; Amah A; Aburub A; Kumar P; Frederick DE; Groot G
    J Patient Rep Outcomes; 2024 Aug; 8(1):101. PubMed ID: 39186150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of the symptom burden questionnaire for long covid (SBQ-LC): Rasch analysis.
    Hughes SE; Haroon S; Subramanian A; McMullan C; Aiyegbusi OL; Turner GM; Jackson L; Davies EH; Frost C; McNamara G; Price G; Matthews K; Camaradou J; Ormerod J; Walker A; Calvert MJ
    BMJ; 2022 Apr; 377():e070230. PubMed ID: 35477524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
    McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
    Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes - The Migraine Functional Impact Questionnaire (MFIQ).
    Hareendran A; Skalicky A; Mannix S; Lavoie S; Desai P; Bayliss M; Thach AV; Mikol DD; Buse DC
    Headache; 2018 Nov; 58(10):1612-1628. PubMed ID: 30374958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of a patient-reported outcome measure for assessing nighttime symptoms of chronic obstructive pulmonary disease.
    Hareendran A; Palsgrove AC; Mocarski M; Schaefer ML; Setyawan J; Carson R; Make B
    Health Qual Life Outcomes; 2013 Jun; 11():104. PubMed ID: 23799883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric evaluation of the Symptoms of Infection with Coronavirus-19 (SIC): results from a cross-sectional study and a phase 3 clinical trial.
    Chan EKH; Williams V; Romano C; Fehnel S; Slagle AF; Stoddard J; Sadoff J; Mayorga M; Lewis S; Yarr S; Ma J; Liu Y; Katz EG; McNulty P; van Dromme I; McQuarrie K
    J Patient Rep Outcomes; 2023 May; 7(1):45. PubMed ID: 37195456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and content validity assessment of the Dry Eye Disease Questionnaire in patients with dry eye disease, meibomian gland dysfunction, and Sjögren's syndrome dry eye disease.
    Sloesen B; Young A; Forde K; Hodson N; Bentley S; Walsh O; Naujoks C; O'Brien P; Sharma G
    J Patient Rep Outcomes; 2023 Jul; 7(1):64. PubMed ID: 37405617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Preliminary Validation of an Instrument to Measure Symptoms and Impacts in Patients with Proliferative Diabetic Retinopathy.
    Rofail D; Sherman S; Hartford C; Levine A; Baldasaro J; Marquis P; Rao R; Do DV
    Adv Ther; 2023 Apr; 40(4):1773-1786. PubMed ID: 36848017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument.
    McCaffrey S; Black RA; Nagao M; Sepassi M; Sharma G; Thornton S; Kim YH; Braverman J
    J Med Internet Res; 2019 Jan; 21(1):e11302. PubMed ID: 30617041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The FATIGUE-PRO: a new patient-reported outcome instrument to quantify fatigue in patients affected by systemic lupus erythematosus.
    Morel T; Cano S; Bartlett SJ; Gordon C; Haier B; Regnault A; Schneider M; Stach C; Cleanthous S
    Rheumatology (Oxford); 2022 Aug; 61(8):3329-3340. PubMed ID: 34897375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Content Validity for the VVSymQ
    Paty J; Elash CA; Turner-Bowker DM
    Patient; 2017 Feb; 10(1):51-63. PubMed ID: 27384669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and content validity of a patient reported outcomes measure to assess symptoms of major depressive disorder.
    Lasch KE; Hassan M; Endicott J; Piault-Luis EC; Locklear J; Fitz-Randolph M; Pathak S; Hwang S; Jernigan K
    BMC Psychiatry; 2012 Apr; 12():34. PubMed ID: 22534028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Development and Content Validation of the Sjögren's Related Quality of Life Instrument (SRQoL).
    Marvel J; Gargon E; Howse C; Chohan A; Mayhew M; Kenney G; Stone L; Fisher BA; Steenackers M; Williamson N; Perella C; Goswami P
    Rheumatol Ther; 2024 Oct; ():. PubMed ID: 39388050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of the Rheumatoid Arthritis Symptom Questionnaire (RASQ): a patient reported outcome scale for measuring symptoms of rheumatoid arthritis.
    Banderas B; Skup M; Shields AL; Mazar I; Ganguli A
    Curr Med Res Opin; 2017 Sep; 33(9):1643-1651. PubMed ID: 28574727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Modular Health-Related Quality of Life Instrument for Electronic Assessment and Treatment Monitoring: Web-Based Development and Psychometric Validation of Core Thrive Items.
    Wicks P; McCaffrey S; Goodwin K; Black R; Hoole M; Heywood J
    J Med Internet Res; 2019 Jan; 21(1):e12075. PubMed ID: 30681962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative interviews to evaluate content validity of the ACTIV-2 COVID-19 Symptom Diary (ACSD).
    Matza LS; Stewart KD; Naegeli AN; Mills KM; Coyne KS; Chew KW; Hughes MD; Smith DM
    J Patient Rep Outcomes; 2023 Jan; 7(1):8. PubMed ID: 36719546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of the Multiple Myeloma Symptom and Impact Questionnaire: A New Patient-Reported Outcome Instrument to Assess Symptom and Impacts in Patients With Multiple Myeloma.
    Gries KS; Fastenau J; Seo C; Potrata B; Iaconangelo C; Serrano D
    Value Health; 2021 Dec; 24(12):1807-1819. PubMed ID: 34838279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.